0001213900-23-067445.txt : 20230815
0001213900-23-067445.hdr.sgml : 20230815
20230815080016
ACCESSION NUMBER: 0001213900-23-067445
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230815
FILED AS OF DATE: 20230815
DATE AS OF CHANGE: 20230815
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROCAMBOLI STEPHEN
CENTRAL INDEX KEY: 0001221451
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39102
FILM NUMBER: 231173242
MAIL ADDRESS:
STREET 1: C/OPARMOUNT CAPITAL
STREET 2: 787 SEVENTH AVE 48TH FL
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TFF Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001733413
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 824344737
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2600 VIA FORTUNA, SUITE 360
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: 737-802-1973
MAIL ADDRESS:
STREET 1: 2600 VIA FORTUNA, SUITE 360
CITY: AUSTIN
STATE: TX
ZIP: 78746
4
1
ownership.xml
OWNERSHIP DOCUMENT
X0508
4
2023-08-15
0
0001733413
TFF Pharmaceuticals, Inc.
TFFP
0001221451
ROCAMBOLI STEPHEN
1751 RIVER RUN, SUITE 400
FORT WORTH
TX
76107
1
0
0
0
0
Common Stock
2023-08-15
4
P
0
20000
0.25
A
36000
D
Acquired from the Issuer pursuant to the public offering described in the Issuer's Prospectus filed with the U.S. Securities and Exchange Commission on August 14, 2023.
/s/ Stephen Rocamboli, by Kirk Allen Coleman, as Attorney-in-Fact
2023-08-15